Team

Rapid Pharma Development Team

Dr. Robert Hett

Managing Partner


Email: robert.hett@rpd-ch.com

Phone:+41 61 599 4886

Mobile CH: +41 79 471 9502

Mobile D: +49 1761 471 9502

Education:
Chemist RWTH-Aachen
Postdoc University of Notre Dame, USA

Key experience:
Business Development, Process Chemistry, API Development, GMP, CRO Management, CMC Project Management, Audits, Patents, Publications, Board member of OPRD

Previous Experience:

Carbogen: Site Manager, of a pilot plant of 80 people, API custom manufacturing for early phase development under c-GMP

Sepracor:
Senior Research Chemist

Dr. Dieter Krimmer

Managing Partner

Email: dieter.krimmer@rpd-ch.com
Phone: +41 41 544 1721

Mobile CH: +41 76 328 3337

Mobile D: +49 1761 328 3337

Education:
Chemist, TH Stuttgart

Key experience:
Project Management, Fermentation, Chemical and Formulation Development, Drug Product, Regulatory Experience (FDA, EMEA, Bfarm), Validation, Qualification, Audits and Inspections

Previous Experience:

Independent Consultant:

CMC Management for e.g. Gilead, Trigen

Hofmann La Roche:

Technical Team Leader for the products INVIRASE®, VIRACEPT®, TAMIFLU®

Freelance Partners

Patrick Page, PhD, MBA
Freelance Consultant for RPD

 

Decode Pharma Partners
3 Cours Charlemagne
69002 Lyon, France
Mobile : +33 6 46 80 05 59
Email: patrick.page@decodepharma-partners.com

Homepage: www.decodepharma-partners.com


Education:
PhD, Biochemistry, Medicinal Chemistry, Uni. of Toulouse; 

MBA, Management in Healthcare, INSEEC Paris

Key experience:

Experienced drug developer and biotech entrepreneur. Founder and co-founder of 3 Biotech companies (Genkyotex on French stock market, Epiremed, Conicmeds). Full-time and part-time executive positions (CEO, CSO, CDO/COO) in several early stage biotech companies. Appointed permanent scientific advisor for the Biopark of Brussels South Charleroi (Wallonia region, BE). 22+ years in pharmaceutical industry: Strategic Project Management, Leadership and Execution, Target Validation, Drug Discovery, Medicinal Chemistry, Preclinical Research and Development, ADME/DMPK/Tox. Filed >25 patents, designed IP and in-licensing strategy, and led patent portfolio for several companies. Inventor and key contributor for Nolasiban, OBE-022, Setanaxib. Major contribution in the birth, business plan, business and R&D strategy, discovery and development plan, and fund raising of several biotechs/spin-off either as executive/non-executive member or acting as a freelance consultant (Genkyotex, Epiremed, Epics Therapeutics, Conicmeds, Gepeceron,…). Multiple due diligence for VC firms, Business angels, TTO and research institutions.

Selected Previous Experience: 

Conicmeds SAS (FR): 

CEO, Director of Preclinical Development and CMC. Membrane nanospacers targeting pulmonary obstructive diseases

Epiremed SAS (FR): 

CSO, Director of Drug Discovery. Compounds targeting epigenetic enzymes for cancers

Genkyotex SA (CH):

Senior Research Advisor. R&D process; Metabolic and Ophtalmological programmes.

Serono Pharma (CH) :

Senior Project Director preclinical development; GPCR, Kinases, Ions channels modulators for several therapeutic indications

Astrazeneca (SE) :

Project Director drug discovery programmes; Discovery research on several programmes

Dr. Olaf Mundszinger

Freelance Consultant for RPD

A&O Pharmadienstleistungen

Am Sattel 17

D 79588 Efringen-Kirchen

Germany

Phone: +49 7628 950 3119

Mobile: +49 170 275 0459

Email: o.mundszinger@aopharma.de

Homepage: www.aopharma.de

 

Education:

Chemist University of Freiburg and Saarland

Study of Pharmaceutical Sciences, QP

 

Key experience:

Qualified Person, GMP, Audits, Pharmaceutical Quality System, Quality Control, Quality Assurance, Validation, IMPD Writing

 

Previous Experience:

Develco Pharma: Head QC, Managing director QA, QP

CU Chemie Uetikon: API manufacturing development, QC

Dr. Timo Schmidt

Freelance Consultant for RPD

Managing Director
Talisto GmbH
Neuhofstrasse 18
CH - 8834 Schindellegi

Switzerland


Phone: +41 44 542 11 20
Mobile: +41 79 969 05 38
Email: t.schmidt@talisto.ch 
Homepage: www.talisto.ch


Education: 
Pharmacist, Universities Würzburg and Munich, Germany 
Ph.D. University of Basel, Switzerland
Executive MBA, Instituto de Empresa, Spain 


Key experience: 
Product Development from concept to technology transfer including regulatory processes, Product Strategy and Life Cycle Management, IP Management, Licensing- and Business Development, RP/QP/fvP services (Switzerland), CDMO and CMC Project Management, Start-Up support (food, pharma, cosmetics). 


Previous Experience: 
EffRx:

Chief Scientific Officer, Member of the management board; overseeing R&D, Regulatory Affairs, Drug Safety, Intellectual Property, Technical Operation and Quality Management. Bone diseases, oncology supportive care, metabolic disease (PCOS)


IDC:

Co-founder, CEO and board member; building a product development and CMC service company from scratch (formulation development, analytical services, technology transfer). Various product classes.

 
Aenova:

Director Corporate R&D; global R&D and product development strategy and -services management for Temmler Group (4 R&D sites, 1 built out), business development, client consulting.


Mepha:

Various roles with increasing responsibilities from sourcing of APIs to international tech transfer and product development. 

Dr. Goran Westerberg, Ph. D.

Freelance Consultant for RPD

La Crocina Pharmaceutical Consultants Lp

Email: goran.westerberg@crocina.com

Homepage: www.crocina.com

Education:
PhD Radiopharmacology, University of Uppsala, Sweden

Key experience:
>30 years in pharmaceutical industry: Clinical and Regulatory Development, Early (Phase I-IIb) clinical studies, Preclinical Development, Due Diligence evaluations, Project Management. Experience from >600 clinical trials, including 36 FTIH studies.

Previous Experience:

Siena Biotech SpA:

Director, Clinical & Regulatory Development. Neuroscience and Oncology programs.

 

Pfizer/Pharmacia Inc:

Director, Clinical Pharmacokinetics. CNS-, Urology-, Oncology and Cardiovascular programs.

 

Pharmacia & Upjohn:

Senior Research Advisor. R&D process; Clinical and Regulatory Management.

 

Uppsala PET Centre:

Associate Director; Clinical Pharmacology studies.

 
 

RPD Rapid Pharma Development GmbH

Zugerstrasse 58a

CH 6314 Unterägeri/Switzerland

rpd-logo-rgb-3100x1200.png